News

Small Pharma CEO Peter Rand & CMSO Dr Carol Routledge at the 34th Annual Roth Conference

View Small Pharma’s Fireside Chat Webcast from the 34th Annual Roth Conference

Monday, March 14 at 3:30 – 3:55PM/PT

Roth Conference Fireside Chat

Watch the Small Pharma Fireside Chat >

Elemer Piros, Senior Research Analyst at Roth Capitol, hosts Small Pharma’s CEO, Peter Rands, and Chief Medical and Scientific Officer, Dr. Carol Routledge, for a fireside chat. 

The Webcast Video is from Monday, March 14. The conversation lasted 23 minutes, covering a number of topics from the foundation of Small Pharma to the joining of Dr Routledge to a discussion of current clinical trials for DMT-assisted therapy in the treatment of Major Depressive Disorder.


For further information contact: 

Small Pharma

Peter Rands
Chief Executive Officer
Email: ir@smallpharma.co.uk
Tel: +44 (0)20 7112 9118

Investor Relations Contacts:

Eric Ribner
LifeSci Advisors
Email: eric@lifesciadvisors.com
Tel: +1 (646)-889-1200

Tim Regan
KCSA Strategic Communications
Email: smallpharmair@kcsa.com
Tel: +1 (347) 487-6788

Media Relations Contacts:

USA
McKenna Miller
KCSA Strategic Communications
Email: smallpharmapr@kcsa.com
Tel: +1 (949) 949-6585

Rest of World
Donna Curran
Hanover Communications
Email: dcurran@hanovercomms.com
Tel: +44 (0)20 7400 4480


About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

With a focus on innovative approaches and committed to challenging the status quo, we’re targeting the root causes of depression and hoping to unlock the minds of millions.

Get Small Pharma updates

    Investor Deck

    Follow us: